Rani Therapeutics Holdings, Inc. (RANI) Social Stream



Rani Therapeutics Holdings, Inc. (RANI): $7.97

-0.09 (-1.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RANI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 376

in industry

RANI THERAPEUTICS HOLDINGS INC (RANI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering RANI THERAPEUTICS HOLDINGS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-22 5 $29 $23 $24.6 $7.89 211.79%
2021-11-23 5 $33 $23 $26.6 $7.89 237.14%
2022-03-30 5 $33 $24 $28.4 $7.89 259.95%
2022-05-13 5 $32 $24 $27.4 $7.89 247.28%
2022-05-16 5 $32 $24 $26.6 $7.89 237.14%
2022-06-13 6 $32 $24 $26.833 $7.89 240.09%
2022-07-29 7 $32 $22 $26.142 $7.89 231.33%
2022-08-10 6 $32 $22 $26.142 $7.89 231.33%
2022-08-19 7 $32 $17 $24.571 $7.89 211.42%
2022-09-17 5 $32 $17 $23.8 $7.89 201.65%
2022-09-29 5 $32 $19 $24.2 $7.89 206.72%
2022-11-11 6 $32 $15 $22.666 $7.89 187.28%
2022-11-13 6 $32 $15 $22.333 $7.89 183.05%

The Trend in the Analyst Price Target


RANI's average price target has moved down $6.07 over the prior 43 weeks.

Over the past 49 weeks, RANI's average upside potential has been 151.05%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-30 5 33 24 28.400 13.43 111.47%
2022-05-13 5 32 24 27.400 11.00 149.09%
2022-05-16 5 32 24 26.600 10.89 144.26%
2022-06-13 6 32 24 26.833 8.00 235.41%
2022-09-29 5 32 19 24.200 9.26 161.34%

RANI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 26 weeks, RANI's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, RANI THERAPEUTICS HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 1337.61% of them.
  • To contextualize these metrics, consider that out of all US stocks, RANI THERAPEUTICS HOLDINGS INC's average analyst price target is greater than 505.54% of them.
  • In terms of how RANI THERAPEUTICS HOLDINGS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 511.98% of that group.
  • RANI THERAPEUTICS HOLDINGS INC's variance in analysts' estimates is lower than -392.6% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, CYBN, DICE, and VAXX are the three stocks most similar to RANI THERAPEUTICS HOLDINGS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for RANI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5656 seconds.